She Ruining, Tian Heyan, Sun Feiyue, Ge Jinwen, Mei Zhigang
Key Laboratory of Hunan Province for Integrated Traditional Chinese and Western Medicine on Prevention and Treatment of Cardio-Cerebral Diseases, College of Integrated Traditional Chinese and Western Medicine, Hunan University of Chinese Medicine, Changsha, Hunan, China; Department of Cardiovascular Medicine, Hunan Hospital of Integrated Traditional Chinese and Western Medicine, 410000, Changsha, Hunan, China.
Key Laboratory of Hunan Province for Integrated Traditional Chinese and Western Medicine on Prevention and Treatment of Cardio-Cerebral Diseases, College of Integrated Traditional Chinese and Western Medicine, Hunan University of Chinese Medicine, Changsha, Hunan, China.
Free Radic Biol Med. 2025 Mar 1;229:139-153. doi: 10.1016/j.freeradbiomed.2025.01.031. Epub 2025 Jan 18.
Cerebral ischemia-reperfusion injury (CIRI) has emerged as a hindrance for rehabilitation of ischemic stroke patients. Naotaifang (NTF) exhibits beneficial efficacy in alleviating inflammation and ferroptosis in vitro during CIRI. While the potential role of NTF in regulating mitochondrial dynamics in CIRI are not elucidated. This study aimed to explore the mechanism of NTF against CIRI by regulating the dynamin-related protein 1 (Drp1)-dependent mitochondrial fission/fusion. Modeling middle cerebral artery occlusion/reperfusion (MCAO/R) in vivo to evaluate the effects of NTF on the MCAO/R-damaged neurons and the structure, dynamics and function of mitochondria. An oxygen-glucose deprivation/reperfusion (OGD/R) cell model was established to evaluate the role of NTF in OGD/R-damaged cells. Function of Drp1 in CIRI and the neuroprotection of NTF through the mitochondrial fission/fusion pathway were investigated in vivo and in vitro. The results revealed that in vivo, NTF alleviated neuron injury in a dose-dependent manner, down-regulated Drp1 and fission protein 1 (Fis1) levels, upregulated optic atrophy 1 (Opa1), mitofusin 1/2 (Mfn1 and Mfn2), facilitated mitochondrial fusion and inhibited mitochondrial fission to rescue cells from CIRI. In vitro, Drp1 overexpression inhibited mitochondrial fusion and activated mitochondrial fission, while silencing of Drp1 exhibited the opposite result. NTF rebalanced mitochondrial dynamic in the OGD/R cell model. NTF could alleviate neuron injury following CIRI by regulating the balance of mitochondrial fission and fusion. Targeting Drp1-dependent mitochondrial dynamics may represent a viable treatment strategy for addressing the issues of CIRI post ischemic stroke.
脑缺血再灌注损伤(CIRI)已成为缺血性中风患者康复的障碍。脑泰方(NTF)在体外减轻CIRI期间的炎症和铁死亡方面显示出有益的疗效。然而,NTF在CIRI中调节线粒体动力学的潜在作用尚未阐明。本研究旨在通过调节动力相关蛋白1(Drp1)依赖性线粒体分裂/融合来探索NTF对抗CIRI的机制。在体内建立大脑中动脉闭塞/再灌注(MCAO/R)模型,以评估NTF对MCAO/R损伤神经元以及线粒体的结构、动力学和功能的影响。建立氧糖剥夺/再灌注(OGD/R)细胞模型,以评估NTF在OGD/R损伤细胞中的作用。在体内和体外研究Drp1在CIRI中的作用以及NTF通过线粒体分裂/融合途径的神经保护作用。结果显示,在体内,NTF以剂量依赖性方式减轻神经元损伤,下调Drp1和分裂蛋白1(Fis1)水平,上调视神经萎缩蛋白1(Opa1)、线粒体融合蛋白1/2(Mfn1和Mfn2),促进线粒体融合并抑制线粒体分裂,从而使细胞从CIRI中恢复。在体外,Drp1过表达抑制线粒体融合并激活线粒体分裂,而Drp1沉默则产生相反的结果。NTF在OGD/R细胞模型中重新平衡了线粒体动力学。NTF可通过调节线粒体分裂和融合的平衡来减轻CIRI后的神经元损伤。靶向Drp1依赖性线粒体动力学可能是解决缺血性中风后CIRI问题的一种可行治疗策略。